B-Cell CLL/lymphoma 7A (BCL7A) (Middle Region) Peptid
Kurzübersicht für B-Cell CLL/lymphoma 7A (BCL7A) (Middle Region) Peptid (ABIN8095368)
Target
Spezies
Quelle
Applikation
-
-
Protein Region
- Middle Region
-
Verwendungszweck
- BCL7A Peptide - middle region
-
Sequenz
- QENSSNSSPA PEPNSAVPSD GTEAKVDEAQ ADGKEHPGAE DASDEQNSQS
-
-
B-Cell CLL/lymphoma 7A (BCL7A) peptide
BCL7A Reaktivität: Human, Rind (Kuh), Hund, Maus, Schwein, Ratte Wirt: Synthetic BP, Imm
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti-BCL7A Antibody(ARP57508_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- BCL7A (B-Cell CLL/lymphoma 7A (BCL7A))
-
Hintergrund
-
Background Information: This gene is directly involved, with Myc and IgH, in a three-way gene translocation in a Burkitt lymphoma cell line. As a result of the gene translocation, the N-terminal region of the gene product is disrupted, which is thought to be related to the pathogenesis of a subset of high-grade B cell non-Hodgkin lymphoma. The N-terminal segment involved in the translocation includes the region that shares a strong sequence similarity with those of BCL7B and BCL7C. Two transcript variants encoding different isoforms have been found for this gene.
Alternative Symbols: BCL7
-
Molekulargewicht
- 25kDa
-
Gen-ID
- 605
-
NCBI Accession
- NP_066273
-
UniProt
- Q4VC05
Target
-
